Universe Pharmaceuticals, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG9442G1120
USD
4.18
0.06 (1.46%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'12
Mar'12
Dec'11
Sep'11
Jun'11
Mar'11
Dec'10
Net Sales
19.06
29.28
46.14
68.01
87.45
90.56
86.94
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
19.06
29.28
46.14
68.01
87.45
90.56
86.94
Raw Material Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
18.94
20.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
13.56
27.55
0.00
0.00
0.00
0.00
0.00
Other Expenses
2.78
2.12
7.23
7.39
13.98
8.94
8.61
Total Expenditure (Excl Depreciation)
60.29
68.73
72.31
73.86
139.78
89.36
86.13
Operating Profit (PBDIT) excl Other Income
-41.2
-39.4
-26.200000000000003
-5.8
-52.300000000000004
1.2
0.8
Other Income
-5.84
0.00
0.00
-8.66
9.00
0.00
0.00
Operating Profit (PBDIT)
-16.25
-42.99
107.32
-9.65
-57.66
-4.62
-4.93
Interest
10.91
9.54
14.85
15.53
18.79
17.96
16.45
Exceptional Items
27.50
0.00
137.42
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
2.52
3.54
3.92
3.80
5.33
5.82
5.74
Profit Before Tax
-77.08
-42.99
-167.52
-18.32
-48.66
-4.62
-4.93
Tax
0.07
0.10
17.17
-7.71
-18.49
-1.75
-1.73
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-77.16
-43.09
-184.69
-10.60
-30.17
-2.86
-3.20
Extraordinary Items
0.00
0.00
4.34
-1.53
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-77.16
-43.09
-184.69
-10.60
-30.17
-2.86
-3.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-77.16
-43.09
-184.69
-10.60
-30.17
-2.86
-3.20
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Reserves
-286.44
-201.35
-152.88
27.47
39.60
69.77
72.64
Earnings per share (EPS)
-3.04
-1.73
-6.52
-0.43
-1.06
-0.1
-0.11
Diluted Earnings per share
-3.04
-1.73
-6.52
-0.43
-1.06
-0.1
-0.11
Operating Profit Margin (Excl OI)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2012 is -78.17% vs 15.13% in Jun 2011

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2012 is -155.63% vs -308.11% in Jun 2011

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2012 is 84.41% vs -602.11% in Jun 2011

stock-summary

Interest

YoY Growth in quarter ended Jun 2012 is -42.02% vs 52.85% in Jun 2011

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2012 has improved from Jun 2011

Compare Quarterly Results Of Universe Pharmaceuticals, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
19.06
0.00
19.06
Other Operating Income
0.00
0.00
0.00
Total Operating income
19.06
0.00
19.06
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
18.94
0.00
18.94
Power Cost
0
0
0.00
Manufacturing Expenses
0
0.13
-0.13
-100.00%
Selling and Distribution Expenses
13.56
1.63
11.93
731.90%
Other Expenses
2.78
0.03
2.75
9,166.67%
Total Expenditure (Excl Depreciation)
60.29
2.04
58.25
2,855.39%
Operating Profit (PBDIT) excl Other Income
-41.23
-2.04
-39.19
-1,921.08%
Other Income
-5.84
0.00
-5.84
Operating Profit (PBDIT)
-16.25
-2.04
-14.21
-696.57%
Interest
10.91
0.13
10.78
8,292.31%
Exceptional Items
27.50
-0.04
27.54
68,850.00%
Gross Profit (PBDT)
0.00
0.00
0.00
Depreciation
2.52
0.00
2.52
Profit Before Tax
-77.08
-2.21
-74.87
-3,387.78%
Tax
0.07
0.00
0.07
Provisions and contingencies
0
0
0.00
Profit After Tax
-77.16
-2.21
-74.95
-3,391.40%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-77.16
-2.21
-74.95
-3,391.40%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-77.16
-2.21
-74.95
-3,391.40%
Equity Capital
0
0
0.00
Face Value
0.01
0.00
0.00
Reserves
-286.44
6.10
-292.54
-4,795.74%
Earnings per share (EPS)
-3.04
-0.46
-2.58
-560.87%
Diluted Earnings per share
-3.04
-0.46
-2.58
-560.87%
Operating Profit Margin (Excl OI)
0%
0.00%
0.00
0.00%
Gross Profit Margin
0%
0.00%
0.00
0.00%
PAT Margin
0%
0.00%
0.00
0.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1.91 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is -34.81% vs -36.44% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is -78.17% vs 15.13% in Jun 2011

Quarterly - Consolidate Net Profit
Consolidate Net Profit -7.72 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is -79.12% vs 76.66% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is -155.63% vs -308.11% in Jun 2011

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.04 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is 75.81% vs -140.07% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is 84.41% vs -602.11% in Jun 2011

Quarterly - Interest
Interest 1.09 Million
in Jun 2012

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2012 is 14.74% vs -35.81% in Mar 2012

stock-summary

YoY Growth in quarter ended Jun 2012 is -42.02% vs 52.85% in Jun 2011

Quarterly - Operating Profit Margin (Excl OI)
Markets Mojo
No Operating Profit Margin (Excl OI) in the last few periods